Fact CheckerSign in

NCT07271927Recruiting

Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease

Evaluation Study of the Effects and Safety of Whole-Body Photobiomodulation Therapy on Motor and Cognitive Changes in Patients With Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 9 Dec 2025

Brief summary (registry, in English)

This study aims to exploratorily evaluate the extent of motor and cognitive changes, as well as the safety, resulting from approximately 10 weeks of whole-body photobiomodulation (PBM) therapy (about three sessions per week, once daily, 20 minutes per session) in patients with Parkinson's disease.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
15 (estimated)
First submitted
21 Aug 2025
Start date
12 Feb 2025
Primary completion date
30 Nov 2025
Lead sponsor
Pusan National University Yangsan Hospital
NCT number
NCT07271927

What you commit to

  • Study type: Interventional
  • Planned participants: 15
  • From 12 Feb 2025 to the primary completion date, 30 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individuals treated for alcohol dependence within 6 months prior to screening

Other illness

  • Individuals with severe cognitive impairment (Korean Mini-Mental State Examination \[K-MMSE\] score ≤ 9) making it difficult to understand and perform tasks
  • Patients with dementia other than Parkinson's disease dementia
  • Individuals with severe neuropsychiatric disorders
  • Individuals with a history of suicide attempts
  • Individuals with a history of seizures
  • Individuals with visual impairment preventing them from reading ordinary text even with corrective lenses
  • Individuals with hearing impairment preventing them from understanding conversation even with a hearing aid

Other

  • Individuals with implanted medical or other electronic devices
  • Individuals experiencing dyspnea while sitting at rest
  • Individuals who have participated in two or more clinical trials in the same year or in another clinical trial within the past 6 months
  • Women and men of childbearing potential who are planning pregnancy during the trial or who do not agree to use appropriate contraceptive methods
  • Pregnant or breastfeeding women
  • Individuals deemed medically inappropriate for participation by the principal investigator or study staff based on clinically significant findings not otherwise specified above

Who the study is looking for

  • Individuals diagnosed with Parkinson's disease at Hoehn and Yahr stages 1-3 based on medical history and examination
  • Adults aged 40 years or older
  • Individuals able to walk independently

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pusan National University Yangsan Hospital
Coordinator of this site? Confirm its status
YangsanSouth KoreaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.